Inventor
KEANA JOHN F W
US77 patents
⚠️ This page may combine multiple inventors who share the name “KEANA JOHN F W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OREGON STATE
31 patentsUS5514680AMay 7, 1996
Glycine receptor antagonists and the use thereof
OREGON STATE206 citations99
US4863717ASep 5, 1989
Methods for circumventing the problem of free radial reduction associated with the use of stable nitroxide free radicals as contrast agents for magnetic reasonance imaging
OREGON STATE142 citations99
US5093525AMar 3, 1992
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE124 citations98
US5582955ADec 10, 1996
Chemical functionalization of surfaces
OREGON STATE109 citations97
US5580697ADec 3, 1996
Chemical functionalization of surfaces
OREGON STATE122 citations97
US5567411AOct 22, 1996
Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group
OREGON STATE113 citations97
US5262568ANov 16, 1993
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE91 citations97
US5412148AMay 2, 1995
Amplifier molecules derived from diethylene triaminepentaacetic acid for enhancement of diagnosis and therapy
OREGON STATE78 citations96
US5336689AAug 9, 1994
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE90 citations96
US5312840AMay 17, 1994
Substituted guanidines having high binding to the sigma receptor and the use thereof
OREGON STATE51 citations96
US5308869AMay 3, 1994
Substituted amidines having high binding to the sigma receptor and the use thereof
OREGON STATE49 citations96
US5190976AMar 2, 1993
N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE107 citations96
US5135737AAug 4, 1992
Amplifier molecules for enhancement of diagnosis and therapy
OREGON STATE56 citations96
US5830539ANov 3, 1998
Methods for functionalizing and coating substrates and devices made according to the methods
OREGON STATE222 citations95
US5465151ANov 7, 1995
Sensors employing interference of electromagnetic waves passing through waveguides having functionalized surfaces
OREGON STATE79 citations94
US5798390AAug 25, 1998
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE26 citations93
US5559154ASep 24, 1996
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE20 citations93
US5620978AApr 15, 1997
8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor
OREGON STATE34 citations92
US5597922AJan 28, 1997
Glycine receptor antagonist pharmacophore
OREGON STATE22 citations92
US5011834AApr 30, 1991
PCP receptor ligands and the use thereof
OREGON STATE40 citations92
US5801183ASep 1, 1998
Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
OREGON STATE38 citations90
US6251948B1Jun 26, 2001
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE17 citations84
US5637622AJun 10, 1997
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE13 citations82
US5622952AApr 22, 1997
Glycine receptor antagonists and the use thereof
OREGON STATE14 citations82
US5478863ADec 26, 1995
Substituted guanidines having high binding to the sigma receptor and the use thereof
OREGON STATE16 citations82
US5631373AMay 20, 1997
Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
OREGON STATE14 citations81
US5767162AJun 16, 1998
Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
OREGON STATE11 citations74
US5620979AApr 15, 1997
Glycine receptor antagonists and the use thereof
OREGON STATE7 citations74
US5604228AFeb 18, 1997
Substituted guanidines having high binding to the sigma receptor and the use thereof
OREGON STATE12 citations74
US5574070ANov 12, 1996
Substituted guanidines having high binding to the sigma receptor and the use thereof
OREGON STATE12 citations74
US5252317AOct 12, 1993
Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid
OREGON STATE12 citations74
CYTOVIA INC
5 patentsUS6335429B1Jan 1, 2002
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
CYTOVIA INC151 citations99
US6342611B1Jan 29, 2002
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
CYTOVIA INC89 citations98
US6759207B2Jul 6, 2004
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof
CYTOVIA INC46 citations96
US6184210B1Feb 6, 2001
Dipeptide apoptosis inhibitors and the use thereof
CYTOVIA INC76 citations95
US6596693B1Jul 22, 2003
Dipeptide apoptosis inhibitors and the thereof
CYTOVIA INC12 citations73
EURO CELTIQUE SA
4 patentsUS6638947B2Oct 28, 2003
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
EURO CELTIQUE SA78 citations98
US6696442B2Feb 24, 2004
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
EURO CELTIQUE SA74 citations97
US6613803B1Sep 2, 2003
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
EURO CELTIQUE SA79 citations97
US6680332B1Jan 20, 2004
Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA
EURO CELTIQUE SA15 citations82
WARNER LAMBERT CO
4 patentsUS6124323ASep 26, 2000
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
WARNER LAMBERT CO54 citations96
US6130234AOct 10, 2000
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
WARNER LAMBERT CO17 citations92
US6218404B1Apr 17, 2001
Subtype-selective NMDA receptor ligands and the use thereof
WARNER LAMBERT CO33 citations90
US6448270B1Sep 10, 2002
4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
WARNER LAMBERT CO6 citations74
SALK INST FOR BIOLOGICAL STUDI
2 patentsADVANCED MICROBOTICS CORP
1 patent(unassigned)
1 patentUNIV OREGON HEALTH SCIENCES
1 patentUNIV CALIFORNIA
1 patentShowing the top 50 of 77 patents by PatentIndex Score.